A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Exclusive manufacturer-reported metrics
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register Today
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 12
Comprehensive Pages
- 14
News Briefs
- 5
Comprehensive News Stories
- 1
Company Spotlight
Latest Industry News & Trends
10/11/2018
orthopedicpress release
Market Scope Announces Launch of New Website and Entry into Orthopedics
.jpg)
Market Scope, an industry leader for ophthalmic market research, announced today the launch of its new website and the firm’s entry into orthopedics, its second medical vertical. The new Market-Sco...
2/15/2019
breakingophthalmic
Stealth Raises $78 Million in Initial Public Offering
Stealth BioTherapeutics raised $78 million in gross proceeds in its initial public offering, the Boston-based company announced Feb. 14. Stealth offered 6.5 million American depositary shares (ADSs...
2/15/2019
breakingophthalmic
Avedro Raises $70 Million in IPO
.png)
Avedro’s initial public offering raised $70 million in gross proceeds, the Waltham, Massachusetts, company announced Feb. 13. The company sold 5 million shares of common stock priced at $14 per sha...
2/15/2019
breakingophthalmic
Samsung Bioepis, C-Bridge Capital to Co-develop Late-Stage Lucentis Biosimilar for China
Korea-based Samsung Bioepis announced Feb. 10 that it is partnering with C-Bridge Capital of Shanghai, China, to develop and commercialize several of its biosimilar candidates, including SB11, whic...
2/15/2019
breakingophthalmic
VSY Biotechnology, Carl Zeiss Meditec Settle Patent Litigation over Trifocal IOL
.png)
Ophthalmic device makers VSY Biotechnology and Carl Zeiss Meditec have settled their patent litigation over VSY’s Tri-ED 611 intraocular lens, VSY announced Feb. 15. The companies agreed not to dis...
2/15/2019
breakingophthalmic
Pr3vent Completes Series A Financing; Company is Developing AI Diagnostic System for Newborns
Pr3vent, a company developing an artificial intelligence-based system for detecting eye disease in newborns, has closed a Series A financing, officials announced Feb. 12. Pr3vent, based in Palo Alt...
2/15/2019
ophthalmic
Iridex, Quantel Medical Dismiss Patent Infringement Suits Against Each Other
.png)
Iridex and Quantel Medical have dismissed lawsuits against each other over patent infringement claims, the two companies announced mid-February. California-based Iridex and France-headquartered Qua...
2/15/2019
breakingophthalmic
Sylentis’ Dry Eye Candidate Misses Primary Endpoints in Phase III Trial
.jpg)
Sylentis’ dry eye candidate failed to meet the primary endpoints in a Phase III study, the Madrid-based company announced Jan. 31. The HELIX trial compared tivanisiran against artificial tears for ...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.